AMGN
Amgen Inc
NASDAQ: AMGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$346.25
+2.43% today
Updated 2026-04-30
Market cap
$182.22B
P/E ratio
23.75
P/S ratio
4.96x
EPS (TTM)
$14.23
Dividend yield
2.80%
52W range
$253 – $391
Volume
2.6M
Amgen Inc (AMGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.39B | $5.40B | $5.99B | $6.34B | $5.79B | $5.12B | $5.88B | $6.29B | $8.55B | $9.08B | $10.35B | $11.18B | $11.30B | $9.15B | $10.50B | $9.26B | $9.72B | $8.47B | $11.49B | $9.96B |
| Capital expenditures | $1.22B | $1.27B | $672.00M | $530.00M | $580.00M | $567.00M | $689.00M | $693.00M | $1.00B | $649.00M | $837.00M | $664.00M | $738.00M | $618.00M | $608.00M | $880.00M | $936.00M | $1.11B | $1.10B | $1.86B |
| Depreciation | $963.00M | $1.20B | $1.07B | $1.05B | $1.02B | $1.06B | $1.09B | $1.29B | $2.09B | $2.11B | $2.10B | $1.96B | $1.95B | $2.21B | $3.60B | $3.40B | $3.42B | $4.07B | $5.59B | $5.17B |
| Stock-based comp | $-81.00M | $81.00M | $17.00M | $284.00M | $353.00M | $341.00M | $362.00M | $403.00M | $408.00M | $322.00M | $311.00M | $329.00M | $311.00M | $308.00M | $330.00M | $341.00M | $401.00M | $431.00M | $530.00M | $494.00M |
| Free cash flow | $4.17B | $4.13B | $5.32B | $5.81B | $5.21B | $4.55B | $5.19B | $5.60B | $7.55B | $8.43B | $9.52B | $10.51B | $10.56B | $8.53B | $9.89B | $8.38B | $8.79B | $7.36B | $10.39B | $8.10B |
| Investing cash flow | $-5.13B | $-1.99B | $-3.17B | $-3.20B | $-4.15B | $-786.00M | $-9.99B | $-8.47B | $-5.75B | $-5.55B | $-8.66B | $-4.02B | $14.34B | $5.71B | $-5.40B | $733.00M | $-6.04B | $-26.20B | $-1.05B | $-1.94B |
| Financing cash flow | $-815.00M | $-2.67B | $-3.07B | $-2.02B | $-1.23B | $-674.00M | $419.00M | $2.73B | $-2.88B | $-3.12B | $-2.60B | $-6.59B | $-22.49B | $-15.77B | $-4.87B | $-8.27B | $-4.04B | $21.05B | $-9.41B | $-10.86B |
| Dividends paid | — | — | — | $1.98B | $0.00 | $500.00M | $1.12B | $1.42B | $1.85B | $2.40B | $3.00B | $3.37B | $3.51B | $3.51B | $3.75B | $4.01B | $4.20B | $4.56B | $4.83B | $5.12B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $1.11B | $403.00M | $3.66B | $-3.69B | $548.00M | $-74.00M | $413.00M | $-903.00M | $559.00M | $3.15B | $-908.00M | $229.00M | $1.72B | $-360.00M | — | — | — |